Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the...

Area of Science:

• Immunology
• Systems Biology
• Oncology

Background:

• The Major Histocompatibility Complex (MHC) presents peptides to T-cells, initiating immune responses against cancer and infections.
• Understanding the relationship between mRNA levels and MHC peptide presentation is vital for systems biology and tumor immunotherapy.

Purpose of the Study:

• To quantitatively analyze the correlation between mRNA levels and MHC peptide densities in renal cell carcinoma.
• To investigate the implications for tumor immunotherapy approaches relying on mRNA expression.

Main Methods:

• Quantitative analysis of mRNA levels using gene chip analysis.
• Quantitative analysis of MHC peptide densities using stable isotope peptide labeling.
• Comparison of over 270 gene expression and peptide presentation ratios in tumor and normal kidney tissues.

Main Results:

• A weak correlation (r = 0.32) was found between mRNA levels and MHC peptide levels in renal cell carcinoma.
• Many presented peptides showed minimal or no change in corresponding mRNA levels.
• Peptides were identified even with undetectable mRNA levels, indicating post-transcriptional regulation.

Conclusions:

• mRNA expression levels do not accurately reflect MHC peptide presentation on the cell surface.
• Tumor-associated antigen epitopes may be missed in studies relying solely on mRNA expression.
• Current mRNA-based approaches provide a distorted view for T-cell recognition in cancer immunotherapy.